Innovative Medical: Cataract trials

The registry lists 15 Cataract studies with Innovative Medical as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 4 14No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract SurgeryCompletedNCT01383057Phase 4
• Laser Cataract Surgery With the Femtosecond Laser TechnologyCompletedNCT01382823Phase 4
• Show Improved Vision With the HOYA AF-1 Aspheric Intraocular Lens After Cataract SurgeryStatus unknownNCT01382641Phase 4
• Dispervise Ophthalmic Viscoelastic as an Agent to Ensure Watertight Wound Closure After Clear Corneal Cataract IncisionsCompletedNCT01298973Phase 4
• Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled TrialCompletedNCT01279031Phase 4
• AMO's Tecnis™ Multifocal Intraocular Lenses (Tecnis MF), Alcon's ReStor Multifocal IOLStatus unknownNCT01278420Phase 4
• Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following PhacoemulsificationStatus unknownNCT01193504Phase 4
• Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular LensesCompletedNCT01061918Phase 4
• Prospective Health Assessment of Cataract Patients' Ocular SurfaceCompletedNCT01016405
• Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug EffectsCompletedNCT00469690Phase 4
• Therapeutic Variables in Cataract SurgeryCompletedNCT00407017Phase 4
• Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL ImplantationCompletedNCT00349583Phase 4
• Acular LS vs. Nevanac in Post op Inflammation Following Cataract SurgeryCompletedNCT00348582Phase 4
• Ketorolac vs. Steroid in the Prevention of CMECompletedNCT00348244Phase 4
• Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract PatientsCompletedNCT00347503Phase 4